Brian C Stephenson insider trades

Open-market stock purchases and sales by Brian C Stephenson, Chief Financial Officer at Faeth Therapeutics, Inc, from SEC Form 4 filings since Jul 1, 2019.

Track record: 5% of 21 scored buys are up 5% or more since purchase, averaging -16%.

Recent trades

DateStockTradeValue
Jul 1, 2026FTH Faeth Therapeutics, IncBought$103K
Jul 1, 2026FTH Faeth Therapeutics, IncBought$14.5K
Jun 30, 2026FTH Faeth Therapeutics, IncBought$43.8K
Jun 30, 2026FTH Faeth Therapeutics, IncBought$39.1K
Jun 30, 2026FTH Faeth Therapeutics, IncBought$106K
Jun 29, 2026FTH Faeth Therapeutics, IncBought$19.4K
Jun 26, 2026FTH Faeth Therapeutics, IncBought$13.7K
Jun 26, 2026FTH Faeth Therapeutics, IncBought$105K
Jun 26, 2026FTH Faeth Therapeutics, IncBought$34.7K
Jun 26, 2026FTH Faeth Therapeutics, IncBought$2.6K
Jun 24, 2026FTH Faeth Therapeutics, IncBought$72.9K
Jun 24, 2026FTH Faeth Therapeutics, IncBought$77.9K
Jun 24, 2026FTH Faeth Therapeutics, IncBought$91.7K
Jun 24, 2026FTH Faeth Therapeutics, IncBought$2.8K
Jun 23, 2026FTH Faeth Therapeutics, IncBought$165K
Jun 23, 2026FTH Faeth Therapeutics, IncBought$48.9K
Jun 23, 2026FTH Faeth Therapeutics, IncBought$11K
Jun 22, 2026FTH Faeth Therapeutics, IncBought$36.4K
Jun 22, 2026FTH Faeth Therapeutics, IncBought$23.3K
Jun 22, 2026FTH Faeth Therapeutics, IncBought$35.5K
Jun 22, 2026FTH Faeth Therapeutics, IncBought$77.5K
Jun 22, 2026FTH Faeth Therapeutics, IncBought$8.5K

Companies traded

  • FTH Faeth Therapeutics, Inc: 22 buys, last Jul 1, 2026
  • BBIO BridgeBio Pharma, Inc: 2 buys, 47 sales, last Feb 25, 2025

Get free alerts when Brian C Stephenson files a new trade →